Tumstatin fragment selectively inhibits neutrophil infiltration in experimental asthma exacerbation.
Gyde NissenHenrike HollaenderFrancesca S M TangMichael WegmannLars LundingChristina VockAnna BachmannSolveig LemmelRainer BartelsBrian G OliverJanette K BurgessTim BeckerMatthias Volkmar KoppMarkus WeckmannPublished in: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology (2018)
CP17 may serve as a potential precursor for drug development to combat overwhelming neutrophil inflammation.